Intravenous Infusions (XGHA:IIL) Days Inventory: 0.00 (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Intravenous Infusions Days Inventory?

Intravenous Infusions XGHA:IIL +8.86% Days Inventory is 0.00 as of . 20. Among 922 Drug Manufacturers companies, Intravenous Infusions ranks worse than 108459.76% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). Intravenous Infusions's Average Total Inventories for the six months ended in . 20 was GHS0.00 Mil. Intravenous Infusions's Cost of Goods Sold for the six months ended in . 20 was GHS0.00 Mil.

The historical rank and industry rank for Intravenous Infusions's Days Inventory or its related term are showing as below:

XGHA:IIL's Days Inventory is not ranked *
in the Drug Manufacturers industry.
Industry Median: 164.72
* Ranked among companies with meaningful Days Inventory only.

Intravenous Infusions's Days Inventory stayed the same from . 20 (0.00) to . 20 (0.00).

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Intravenous Infusions  (XGHA:IIL) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Intravenous Infusions's Inventory Turnover for the six months ended in . 20 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Intravenous Infusions's Inventory to Revenue for the six months ended in . 20 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Intravenous Infusions Days Inventory Related Terms


Intravenous Infusions Days Inventory Historical Data

* Premium members only.

The historical data trend for Intravenous Infusions's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Intravenous Infusions Days Inventory Chart

Intravenous Infusions Annual Data
Trend
Days Inventory

Intravenous Infusions Semi-Annual Data
Days Inventory

XGHA:IIL vs PTLF, PCYN, YBAO: Days Inventory Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Intravenous Infusions's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intravenous Infusions Days Inventory vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intravenous Infusions's Days Inventory distribution charts can be found below:

* The bar in red indicates where Intravenous Infusions's Days Inventory falls into.



Intravenous Infusions Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Intravenous Infusions's Days Inventory for the fiscal year that ended in . 20 is calculated as

Days Inventory (A: . 20 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: . 20 ) + Total Inventories (A: . 20 )) / count ) / Cost of Goods Sold (A: . 20 )*Days in Period
=( ( + ) / 1 ) / *365
=0 / *365
=N/A

Intravenous Infusions's Days Inventory for the quarter that ended in . 20 is calculated as:

Days Inventory (Q: . 20 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: . 20 ) + Total Inventories (Q: . 20 )) / count ) / Cost of Goods Sold (Q: . 20 )*Days in Period
=( ( + ) / 1 ) / *365 / 2
=0 / *365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 0.00 mean?
Intravenous Infusions (XGHA:IIL) has a Days Inventory of 0.00 as of . 20. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Intravenous Infusions and its competitors. According to the industry distribution chart, Intravenous Infusions ranks #999999 out of 922 companies in the Drug Manufacturers industry.
Is Intravenous Infusions' Days Inventory too high?
Intravenous Infusions' current Days Inventory is 0.00. Based on the distribution chart, Intravenous Infusions ranks #999999 out of 922 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Intravenous Infusions' Days Inventory compare to PTLF and PCYN?
According to the Drug Manufacturers industry distribution chart, Intravenous Infusions ranks #999999 out of 922 companies for Days Inventory. This places Intravenous Infusions in the lower half of its industry. The industry median Days Inventory is 164.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.72, based on 922 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Intravenous Infusions and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Intravenous Infusions's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Intravenous Infusions stock overvalued right now?
Intravenous Infusions (XGHA:IIL) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Intravenous Infusions (XGHA:IIL), the current Days Inventory is 0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Intravenous Infusions Business Description

Address Plot 4/7 Blk L, P.O Box KF 63, Effiduase-Koforidua, GHA
Intravenous Infusions Ltd engages in the production of intravenous infusion and small-volume injectables for therapeutic purposes. The product categories are IV fluids, giving sets, and small-volume injectables. The company earns a majority of its revenue from IV fluids. Some of the IV fluids are sodium chloride solutions, dextrose solutions, dextrose saline solutions, and dextran solutions. Small-volume injectables include pethidine injection, magnesium sulphate injection, and quinine injection. Giving sets include plain giving sets, and blood giving sets.